Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
4.
Eur J Clin Microbiol Infect Dis ; 43(1): 55-59, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-37924444

RESUMO

Human sapovirus (HuSaV) is a common cause of gastroenteritis worldwide and is responsible for approximately 4% of acute gastroenteritis episodes in Europe. As reported with norovirus, patients with immunocompromised states are at increased risk of developing HuSaV infection, which can lead to persistent diarrhea and chronic viral shedding in some individuals. Chronic infections are incompletely investigated in these patients, and, due to the lack of specific treatment for HuSaV infection, different clinical approaches were carried out in order to provide further evidence on clinical evolution of these patients with different treatments. In this retrospective study, we report five immunocompromised pediatric patients with recurrent diarrhea caused by HuSaV and long-term viral shedding. Stool samples were analyzed by real-time PCR and tested for enteropathogenic viruses and bacteria and protozoa. Among transplant recipients, reduction of immunosuppressant therapy led to clinical improvement and relief of symptoms, maintaining a balance between managing the infection and preventing graft rejection. Nitazoxanide for 14 days was only used in one of these patients, showing to be an effective therapy to achieve reduction in time to resolution of symptoms. Neither nitazoxanide nor modification of immunosuppressant therapy could avoid recurrences. Further investigations are needed to develop new approaches that can both clear the infection and avoid persistent diarrhea in these patients.


Assuntos
Infecções por Adenovirus Humanos , Infecções por Caliciviridae , Infecções por Enterovirus , Gastroenterite , Sapovirus , Humanos , Criança , Lactente , Sapovirus/genética , Estudos Retrospectivos , Infecções por Caliciviridae/diagnóstico , Gastroenterite/diagnóstico , Diarreia/diagnóstico , Imunossupressores , Fezes
5.
Anaerobe ; 84: 102803, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37984560

RESUMO

Infections from anaerobic microorganisms result from breached mucosal barriers, posing a significant mortality risk. A retrospective study at Hospital Universitario La Paz (Madrid) from 2010 to 2022 analyzed 491 (6.17 %) anaerobic bacteremia cases out of 7956 significant bacteremia cases among 171,833 blood culture requests. Bacteroides fragilis was the most frequently isolated species (28.3 %), followed by Clostridium perfringens (13.6 %). B. fragilis showed good susceptibility to amoxicillin/ clavulanic acid (86 %), piperacillin/tazobactam (86 %), and metronidazole (87.7 %). In general, non-fragilis Bacteroides species showed low susceptibility to penicillin (7 %), amoxicillin (17.5 %), and clindamycin (64.9 %). Of our 13 non-perfringens Clostridium isolates, four exhibited resistance to penicillin and four showed resistance to clindamycin. Lactobacillus species were highly susceptible to antibiotics tested. Prevotella spp. showed low susceptibility to penicillin (20 %), amoxicillin (20 %), and clindamycin (40 %). The study contributes valuable data for monitoring and improving anaerobic bacteremia treatment.


Assuntos
Bacteriemia , Bactérias Anaeróbias , Humanos , Clindamicina , Estudos Retrospectivos , Centros de Atenção Terciária , Testes de Sensibilidade Microbiana , Antibacterianos/farmacologia , Bacteriemia/tratamento farmacológico , Bacteriemia/microbiologia , Combinação Piperacilina e Tazobactam , Bacteroides fragilis , Amoxicilina , Combinação Amoxicilina e Clavulanato de Potássio , Clostridium perfringens
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...